RxDoctor Payments Data

Kristy Crandell, MD

Family Medicine · Red Bay, ALNPI 1578500146

Payments from drug & device makers

$1,230in general payments, 2019–2025

Across 76 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$359
  • Novo Nordisk$236
  • AbbVie$191
  • Merck$109
  • Esperion Therapeutics, Inc.$77
  • GSK$64
  • plus $193 from 7 others

What the payments were for

  • Food & beverage$1,230100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,230 in reported general payments places this provider in the 60th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$239,814
Medicare patients
207
Services billed
9,418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide119$122,632
EliquisApixaban122$95,291
TrulicityDulaglutide75$73,001
Trelegy ElliptaFluticasone/Umeclidin/Vilanter96$60,339
RybelsusSemaglutide44$57,918
Repatha SureclickEvolocumab96$51,053
OzempicSemaglutide50$49,033
JardianceEmpagliflozin43$35,709
Xtampza ErOxycodone Myristate28$27,851
Tresiba Flextouch U-200Insulin Degludec43$25,615
MyrbetriqMirabegron43$22,734
PentasaMesalamine11$16,120
TrintellixVortioxetine Hydrobromide22$14,512
Xigduo XrDapaglifloz Propaned/Metformin20$11,110
Lagevrio (Eua)Molnupiravir12$11,017

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$27$195,633194 claims
Novo NordiskRybelsus, Ozempic$236$106,95194 claims
GSKTrelegy Ellipta, Shingrix, Breo Ellipta$64$78,323164 claims
MerckLagevrio (Eua), Janumet Xr, Januvia$109$31,25647 claims
Astellas Pharma US IncMyrbetriq$27$22,73443 claims
AbbVieSavella, Synthroid$191$16,12891 claims
NovartisEntresto$36$8,12112 claims
AstraZenecaBrilinta$22$5,09312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Red Bay

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →